Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test results
Author:
Funder
German Cancer Aid
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference35 articles.
1. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial;Albain;Lancet Oncol,2010
2. Gene expression profiling predicts clinical outcome of breast cancer;van ’t Veer;Nature,2002
3. Van ’t Veer LJ: the predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer;Knauer;Breast Canc Res Treat,2010
4. Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone;Gnant;Ann Oncol,2014
5. Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework;Biomarkers in Medicine;2024-03-15
2. Use of the Gene Expression Test Prosigna® in Premenopausal Patients with HR+, HER2− Early Breast Cancer: Correlation of the Results with the Proliferation Marker Ki-67;Breast Care;2023-10-17
3. Dysregulated Expression of LncRNA-SChLAP1 in Breast Cancer;Journal of Biomedical Nanotechnology;2023-10-01
4. Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer;Breast Cancer Research and Treatment;2023-03-03
5. Expression, assessment and significance of Ki67 expression in breast cancer: an update;Journal of Clinical Pathology;2023-02-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3